Colgate Palmolive (CL) Equity Average (2009 - 2026)

Colgate Palmolive's Equity Average history runs 18 years deep, the most recent figure standing at $425.5 million for Q1 2026.

• In Q1 2026, Equity Average fell 96.17% year-over-year to $425.5 million; the TTM figure through Mar 2026 stood at $425.5 million (down 96.17% YoY), while the FY2025 annual figure was -$1.9 billion, up 87.24% from the prior year.
• Equity Average was $425.5 million for Q1 2026 at Colgate Palmolive, down from $610.5 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $14.1 billion in Q3 2023 to a low of -$24.6 billion in Q2 2022.
• Historically, Equity Average has averaged -$2.9 billion across 5 years, with a median of -$487.5 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Equity Average slumped 2528.72% in 2024, then jumped 1626.25% in 2025.
• A 5-year view of Equity Average shows it stood at -$14.7 billion in 2022, then jumped by 95.07% to -$723.0 million in 2023, then surged by 94.47% to -$40.0 million in 2024, then surged by 1626.25% to $610.5 million in 2025, then tumbled by 30.3% to $425.5 million in 2026.
• The last three Equity Average figures came in at $425.5 million (Q1 2026), $610.5 million (Q4 2025), and -$13.5 billion (Q3 2025), per Business Quant data.